ARTICLE | Finance
Akouos’ first-day pop outshines peers among NASDAQ IPO trio
Fusion, PolyPid join the gene therapy company on NASDAQ, Hyloris prices IPO on Euronext
June 26, 2020 9:19 PM UTC
Among a trio of companies making their NASDAQ debuts on Friday, Akouos’ first-day rise of 29% was the biggest, while Fusion gave back its early gains and PolyPid also climbed in the aftermarket.
Across the Atlantic, Belgian drug reformulation company Hyloris Pharmaceuticals S.A. (Euronext:HYL) raised €62 million ($69 million) in an IPO on Euronext Brussels...